Skip to content

Effect of time-restricted feeding in combination with short-cating oral contraceptives on PCOS: A prospective randomized controlled trial

Effect of time-restricted feeding in combination with short-cating oral contraceptives on PCOS: A prospective randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078263
Enrollment
Unknown
Registered
2023-12-01
Start date
2022-02-01
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic Ovary Syndrome

Interventions

Intervention group (Group TRF):Subjects in the TRF group were instructed to adhere to a strict 8 hour time-restricted eating for 12 weeks, while also regularly taking drospirenone and ethinylestradiol
Control group (Group COC):Regularly taking drospirenone and ethinylestradiol II for 12 weeks

Sponsors

The First People's Hospital of Foshan
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Female aged 18-40 years; 2. Women diagnosed with PCOS according to Rotterdam criteria; 3. Sign the informed consent voluntarily and be willing to participate in this study.

Exclusion criteria

Exclusion criteria: 1. Accompanied by coexisting endocrine disorders; 2. Individuals who had received corticosteroid treatment within the past 12 weeks; 3. Taking medications that may impact glucose and lipid metabolism, such as insulin, glyburide, indomethacin, phentolamine, furosemide, phenytoin sodium, cortisone, etc., within the last month; 4. Concomitant with conditions affecting glucose and lipid metabolism like thyroid dysfunction, asthma, hypertension, diarrhea, inflammatory bowel disease (IBD), intestinal stress syndrome (ISS), gastrointestinal surgery etc.; 5. Smokers and alcohol consumers; 6. Uncontrolled psychiatric disorders (including a history of hospitalization for mental illness); 7. Currently using any medication targeting or known to affect appetite; 8. Presently enrolled in weight loss or weight management programs/courses; 9. Pregnant or breastfeeding women.

Design outcomes

Primary

MeasureTime frame
Spontaneous ovulation;

Secondary

MeasureTime frame
Serum glucose;Serum insulin;Triglyceride;Cholesterol;High-density lipoprotein;Low-density lipoprotein;Estradiol;Progesterone;Follicle stimulating hormone;Luteinizing hormone;Total testosterone;Prolactin;Uric Acid;Creatinine;Weight;Waist-hip ratio;

Countries

China

Contacts

Public ContactZhu Minshan

The First People's Hospital of Foshan

shanzhu_2023@qq.com+86 180 3886 1839

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026